OrganX is the World's leading multi-organ health technologies NGO established to eXponentially accelerate advances in Organ care combining translational biomedical research with cutting-edge digital health technologies
OrganX is a Non-Profit Health Organization (NPHO)
We were initially created to accelerate the digitalization of the transplantation care continuum and establish / govern the first global Blockchain-powered AI-supported solid organs exchange and tokenized ecosystem in the world (ORGAN eXchange).
The advanced technological capabilities we have developed for transplantation attracted many requests for research grants, donations and partnerships to revolutionize the diagnostic, treatment and monitoring of chronic organ diseases, organ failure and organ transplantation.
This led us to rapidly broaden our scope to become the world's leading multi-Organ health technologies non-profit organization, leveraging our expertise in Digital Health, AI, Blockchain, Gene Expression and Transcriptomics to accelerate the development, use and adoption of Medical AI in all dimensions of organ care.
The purpose is to work on frontier technologies that the private sector is currently unable or unwilling to develop because too risky or early in the research and development continuum. These technologies can later be transferred to the private sectors if proven viable.
OrganX now stands for ORGANXponential !!
Our vision is to change the practice of medicine by working on early technologies not currently ready for prime time. That's where a Non-Profit Health Organization differentiates itself from the private sector: guided by patients, not profits.
Our goals goals directly align with WHO Digital Health's objectives. WHO believes that the use and scale up of digital health solutions can revolutionize how people worldwide achieve higher standards of health, and access services to promote and protect their health and well-being.
Digital health provides opportunities to accelerate progress in healthcare related Sustainable Development Goals (especially SDG 3) and achieving the triple billion targets -improve the health of 3 billions people by 2023- as articulated in United Nations WHO's Thirteenth General Program of Work
We established the first Blockchain Organs Exchange in the World supported by clinical institutions
At a time of global organs scarcity, this concept is going to revolutionize solid organs transplantation worldwide, combining Blockchain with AI
The exchange is operated on a nonprofit basis and aligns the incentives of all stakeholders along the transplantation continuum by making its processes more effective, efficient, transparent, secured and trustworthy - Creating a fully virtualized and tokenized transplant ecosystem with trust at its core
We leverage advanced AI combined with transcriptomics and gene expression capabilities to enhance current clinical practice
These minimally invasive AI-piloted diagnostics are improving disease monitoring, clinical decision, and patients’ outcome
For example, our world class Cell-Free DNA AI Platform (cfDNA-AI) allows us to develop solutions in the field of Transplantation, Oncology, Cardiology or Inflammation
This platform therefore increases the ability to detect allograft injuries, multiple cancer types, autoimmune diseases or disease progression much earlier and more accurately than the standard of care through AI augmentation of recent biological and molecular testing technologies
We provide assistance to world-leading institutions to optimize the design, operationalization and outcomes of their clinical trials in the field of NCDs in fields where private entities do not have the expertise
We leverage our unique access to highly qualified and vetted translational and longitudinal healthcare databases to develop and train our advanced algorithms
This allows us to identify and segment patients, identify and validate potential drug candidates and biological targets with unprecedented accuracy and speed, reducing CAPEX, increasing ROI and mitigating risks
Our Public-Private-Partnership platform allows us to support countries in the developing world with under-invested healthcare ecosystems - particularly Africa
We partner with Healthcare Authorities (HAs), HealthCare Organizations (HCOs) and Research Institutions (RIs) to set-up local or pan-countries biomedical research platforms and support research
A small proportion of research activities are performed out of developing counties and we ought to change this. Also, a lot of diseases prevalent in these countries are not well understood, diagnosed and treated, and would benefit from advanced digital technologies to further their understanding - especially the growing burden of NCDs
We have developed a platform which could allow to design clinically-relevant algorithms
These algorithms can be used to support clinical decision making for diagnosis, prognosis or patient monitoring across the disease continuum. They can be enhanced with IoT based solutions for real-time real-world-evidence collection and analysis
They all demonstrate significant clinical utility, substantial value savings for the healthcare ecosystem and advancements to the practice of medicine
The virtual platforms and regulated digital medical devices we develop with our partners lead to substantial improvements in quality of life and life expectancy of patients affected by severe NCDs versus current standard of care
Copyright © 2020 OrganX - All Rights Reserved
Powered by AI & Blockchain